Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
2020 ◽
Vol 9
(1)
◽
pp. 1-3
Jacques De Greve
◽
Philippe Giron
2021 ◽
Vol 16
(3)
◽
pp. S666-S667
K. Yamamoto
◽
M. Kuwahara
◽
S. Yamamoto
2014 ◽
Vol 25
◽
pp. iv452
K. Otsuka
◽
A. Hata
◽
R. Kato
◽
J. Takeshita
◽
C. Okuda
◽
...
2017 ◽
Vol 96
(7)
◽
pp. e6151
◽
Jin-Qiu Yuan
◽
Yue-Lun Zhang
◽
Hai-Tao Li
◽
Chen Mao
2018 ◽
Vol 15
(8)
◽
pp. 3216-3226
◽
Chang Liu
◽
Tatiana Shaurova
◽
Suzanne Shoemaker
◽
Martin Petkovich
◽
Pamela A. Hershberger
◽
...
2019 ◽
pp. 089719001984059
Emily Miao
◽
Nagashree Seetharamu
◽
Kevin Sullivan
◽
Stephen Eng
◽
Chung-Shien Lee
2014 ◽
Vol 25
◽
pp. iv450
T. Vavala
◽
A. Follador
◽
M. Tiseo
◽
D. Galetta
◽
A. Montanino
◽
...
2019 ◽
Vol 133
◽
pp. 145-159
◽
Nishant S. Kulkarni
◽
Vineela Parvathaneni
◽
Snehal K. Shukla
◽
Leonard Barasa
◽
Jeanette C. Perron
◽
...
Sucheta Kulkarni
◽
Leya Saju
◽
Carol F. Farver
2017 ◽
Vol 22
◽
pp. 114-114
◽